Clinical Trial Update: The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating recombinant luteinizing hormone supplementation in patients with suboptimal response to recombinant follicle-stimulating hormone underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• recombinant FSH (follicle-stimulating hormone)
• recombinant LH (recombinant luteinizing hormone)

Snippet

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital | Conditions: Infertility | Phase 4 | Status: COMPLETED | Results posted: 2014-08-19